Cargando…

Identification and in silico analysis of a spectrum of SLC4A11 variations in Indian familial and sporadic cases of congenital hereditary endothelial dystrophy

BACKGROUND: Congenital hereditary endothelial dystrophy (CHED) is a rare form of corneal dystrophy caused by SLC4A11 gene variations. This study aims to find the genetic alterations in SLC4A11, in two Indian familial CHED cases with affected members n = 3 and n = 2 respectively and five sporadic CHE...

Descripción completa

Detalles Bibliográficos
Autores principales: Salman, Mohd, Verma, Anshuman, Chaurasia, Sunita, Prasad, Deeksha, Kannabiran, Chitra, Singh, Vivek, Ramappa, Muralidhar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482203/
https://www.ncbi.nlm.nih.gov/pubmed/36115991
http://dx.doi.org/10.1186/s13023-022-02521-4
_version_ 1784791401844703232
author Salman, Mohd
Verma, Anshuman
Chaurasia, Sunita
Prasad, Deeksha
Kannabiran, Chitra
Singh, Vivek
Ramappa, Muralidhar
author_facet Salman, Mohd
Verma, Anshuman
Chaurasia, Sunita
Prasad, Deeksha
Kannabiran, Chitra
Singh, Vivek
Ramappa, Muralidhar
author_sort Salman, Mohd
collection PubMed
description BACKGROUND: Congenital hereditary endothelial dystrophy (CHED) is a rare form of corneal dystrophy caused by SLC4A11 gene variations. This study aims to find the genetic alterations in SLC4A11, in two Indian familial CHED cases with affected members n = 3 and n = 2 respectively and five sporadic CHED cases using direct sequencing, followed by in silico analysis and characterization of the identified variants. RESULTS: All three affected members of the first CHED family were identified with a novel homozygous c.1514C > G (p.Ser489Trp) variation while second family showed presence of a compound heterozygous variation c.529A > C (p.Arg161Arg) + c.2461insT (p.Val805fs). Among five sporadic cases, two showed novel changes, homozygous c.1487G > T (p.Ser480Ile) and c.620-2A > G, while the other one had previously reported homozygous c.2653C > T (p.Arg869Cys) variation. The remaining two cases did not reveal the presence of SLC4A11-related pathogenic variations. The identified variations were excluded from the Indian control (n = 80). In silico analysis using homology-based protein modeling and pathogenicity prediction tools, which revealed these alterations as pathogenic, changing their protein stability, local flexibility, residue contact clashes, and the hydrogen bond interactions. CONCLUSIONS: This study contributed to the CHED mutational spectrum, adding four novel variations and confirming a previously reported one. It demonstrates different type of variations in CHED cases, including coding, non-coding, homozygous, synonymous, and compound heterozygous variations. The identified variations revealed different degrees of pathogenic effects in silico. Moreover, two sporadic cases could not be identified with pathogenic variation emphasizing the involvement of other genes or genetic mechanisms. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-022-02521-4.
format Online
Article
Text
id pubmed-9482203
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-94822032022-09-18 Identification and in silico analysis of a spectrum of SLC4A11 variations in Indian familial and sporadic cases of congenital hereditary endothelial dystrophy Salman, Mohd Verma, Anshuman Chaurasia, Sunita Prasad, Deeksha Kannabiran, Chitra Singh, Vivek Ramappa, Muralidhar Orphanet J Rare Dis Research BACKGROUND: Congenital hereditary endothelial dystrophy (CHED) is a rare form of corneal dystrophy caused by SLC4A11 gene variations. This study aims to find the genetic alterations in SLC4A11, in two Indian familial CHED cases with affected members n = 3 and n = 2 respectively and five sporadic CHED cases using direct sequencing, followed by in silico analysis and characterization of the identified variants. RESULTS: All three affected members of the first CHED family were identified with a novel homozygous c.1514C > G (p.Ser489Trp) variation while second family showed presence of a compound heterozygous variation c.529A > C (p.Arg161Arg) + c.2461insT (p.Val805fs). Among five sporadic cases, two showed novel changes, homozygous c.1487G > T (p.Ser480Ile) and c.620-2A > G, while the other one had previously reported homozygous c.2653C > T (p.Arg869Cys) variation. The remaining two cases did not reveal the presence of SLC4A11-related pathogenic variations. The identified variations were excluded from the Indian control (n = 80). In silico analysis using homology-based protein modeling and pathogenicity prediction tools, which revealed these alterations as pathogenic, changing their protein stability, local flexibility, residue contact clashes, and the hydrogen bond interactions. CONCLUSIONS: This study contributed to the CHED mutational spectrum, adding four novel variations and confirming a previously reported one. It demonstrates different type of variations in CHED cases, including coding, non-coding, homozygous, synonymous, and compound heterozygous variations. The identified variations revealed different degrees of pathogenic effects in silico. Moreover, two sporadic cases could not be identified with pathogenic variation emphasizing the involvement of other genes or genetic mechanisms. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-022-02521-4. BioMed Central 2022-09-17 /pmc/articles/PMC9482203/ /pubmed/36115991 http://dx.doi.org/10.1186/s13023-022-02521-4 Text en © The Author(s) 2022, corrected publication 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Salman, Mohd
Verma, Anshuman
Chaurasia, Sunita
Prasad, Deeksha
Kannabiran, Chitra
Singh, Vivek
Ramappa, Muralidhar
Identification and in silico analysis of a spectrum of SLC4A11 variations in Indian familial and sporadic cases of congenital hereditary endothelial dystrophy
title Identification and in silico analysis of a spectrum of SLC4A11 variations in Indian familial and sporadic cases of congenital hereditary endothelial dystrophy
title_full Identification and in silico analysis of a spectrum of SLC4A11 variations in Indian familial and sporadic cases of congenital hereditary endothelial dystrophy
title_fullStr Identification and in silico analysis of a spectrum of SLC4A11 variations in Indian familial and sporadic cases of congenital hereditary endothelial dystrophy
title_full_unstemmed Identification and in silico analysis of a spectrum of SLC4A11 variations in Indian familial and sporadic cases of congenital hereditary endothelial dystrophy
title_short Identification and in silico analysis of a spectrum of SLC4A11 variations in Indian familial and sporadic cases of congenital hereditary endothelial dystrophy
title_sort identification and in silico analysis of a spectrum of slc4a11 variations in indian familial and sporadic cases of congenital hereditary endothelial dystrophy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482203/
https://www.ncbi.nlm.nih.gov/pubmed/36115991
http://dx.doi.org/10.1186/s13023-022-02521-4
work_keys_str_mv AT salmanmohd identificationandinsilicoanalysisofaspectrumofslc4a11variationsinindianfamilialandsporadiccasesofcongenitalhereditaryendothelialdystrophy
AT vermaanshuman identificationandinsilicoanalysisofaspectrumofslc4a11variationsinindianfamilialandsporadiccasesofcongenitalhereditaryendothelialdystrophy
AT chaurasiasunita identificationandinsilicoanalysisofaspectrumofslc4a11variationsinindianfamilialandsporadiccasesofcongenitalhereditaryendothelialdystrophy
AT prasaddeeksha identificationandinsilicoanalysisofaspectrumofslc4a11variationsinindianfamilialandsporadiccasesofcongenitalhereditaryendothelialdystrophy
AT kannabiranchitra identificationandinsilicoanalysisofaspectrumofslc4a11variationsinindianfamilialandsporadiccasesofcongenitalhereditaryendothelialdystrophy
AT singhvivek identificationandinsilicoanalysisofaspectrumofslc4a11variationsinindianfamilialandsporadiccasesofcongenitalhereditaryendothelialdystrophy
AT ramappamuralidhar identificationandinsilicoanalysisofaspectrumofslc4a11variationsinindianfamilialandsporadiccasesofcongenitalhereditaryendothelialdystrophy